EP Patent

EP3738584A1 — Granulate containing eslicarbazepine acetate, its production, pharmaceutical preparations containing it, and their use

Assigned to Meditop Gyogyszeripari Korlatolt Felelossegu Tarsasag · Expires 2020-11-18 · 5y expired

What this patent protects

The object of the invention relates to granules containing or substantially consisting of eslicarbazepine acetate and L-HPC, to the production and use of such granules, and to tablets or capsules containing such granules.

USPTO Abstract

The object of the invention relates to granules containing or substantially consisting of eslicarbazepine acetate and L-HPC, to the production and use of such granules, and to tablets or capsules containing such granules.

Drugs covered by this patent

Patent Metadata

Patent number
EP3738584A1
Jurisdiction
EP
Classification
—
Expires
2020-11-18
Drug substance claim
No
Drug product claim
No
Assignee
Meditop Gyogyszeripari Korlatolt Felelossegu Tarsasag
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.